ment was recommended, but the patient initially refused. As the clinical findings did not change during follow-up, surgery was performed in August 2014. Restriction of the inferior rectus muscle of the left eye was confirmed through the forced duction test. During surgery, conjunctival scarring over the inferior rectus muscle was noted, in addition to a linear scar along the medial border of the muscle. The inferior rectus muscle of the left eye was recessed by 5 mm and the superior rectus muscle of the right eye was recessed by 5 mm. The postoperative ocular alignment showed orthotropia, and the patient achieved binocular single vision (Fig. 1) .
STA is becoming increasingly popular because it provides good analgesia without the passage of sharp needles in the orbit. The reported complications of STA include subconjunctival hemorrhage, chemosis, extraocular muscle paresis, and optic neuropathy [2, 3] . Postoperative diplopia following cataract surgery under STA is particularly disconcerting for the surgeon. Jaycock et al reported three cases of persistent rectus muscle restriction after STA [4] . They postulated that direct trauma to the muscle with hematoma formation occurred at the time of the STA with subsequent contracture of the affected muscle. We agree with their hypothesis based on our surgical findings. Although inferior rectus muscle restriction after STA is uncommon, the surgeon needs to be aware of this possibility; care must always be taken to avoid direct trauma to the muscle during the procedure.
Won Jae Kim, Myung Mi Kim Retinal capillary hemangioma (RCH) is a benign capillary angiomatous hamartoma that occurs on the peripheral or juxtapapillary retina. The condition in which RCH is accompanied by intracranial hemangioblastomas and cysts in abdominal organs such as kidneys or pancreas is termed von Hippel-Lindau (VHL) disease. Photo dynamic therapy (PDT) with anti-vascular endothelial growth factor agents is an effective treatment for RCH [1] , although exudative complications can occur following PDT in rare cases [2] [3] [4] . Herein, we present a case of massive exudative retinal detachment involving the entire retina following the administration of PDT with intrav itreal injection of bevacizumab in a patient with VHL disease.
A 24-year-old man was referred to our hospital with a history of impaired vision in his left eye. On admission, his visual acuity was 20 / 100 in the left eye, and his medical history revealed a previous diagnosis of VHL disease with multiple cerebellar hemangioblastomas and renal cell carcinoma. Furthermore, the patient had a family history of VHL disease, and genetic analyses revealed a mutation in the VHL tumor suppressor gene (VHL gene). Two months prior to the development of visual symptoms, he had undergone suboccipital craniectomy and excision of the cerebellar hemangioblastomas. Fundus examination revealed an inferonasal, 2-disc diameter-sized RCH with dilated feeder vessels (Fig. 1A) . The patient was recommended PDT, which he declined.
Two years later, the patient revisited our clinic with a complaint of double vision. The visual acuity in his left eye was 20 / 1,000, and fundus examination revealed an enlarged RCH with exudation ( Fig. 1B and 1C) . Optical coherence tomography revealed subretinal f luid accumulation with macular involvement (Fig. 1D) .
PDT with a 6 mg/m 2 (body surface area) dose of verteporfin over a period of 10 minutes and a light expo sure of 50 J/cm 2 5 minutes after intravenous verteporfin injection were administered in combination with an intravitreal injection of 1.25 mg/0.05 mL bevacizumab (Avastin; Genentech-Roche, South San Francisco, CA, USA). Fourteen days after PDT and intravitreal bevacizumab injection, the patient's visual acuity in the left eye progressed to no light perception. Funduscopy revealed total retinal detachment with massive exudation and hemorrhage from the RCH (Fig. 1E and 1F) . After 21 days, his visual acuity showed no improvement, and total retinal detachment was still apparent. Consequently, we performed pars plana vitrectomy, internal subretinal f luid drainage retinotomy, endodiathermy, cryotherapy and endolaser therapy on the RCH, and injection of silicone oil and bevacizumab.
Two months after surgery, his visual acuity in the left eye recovered slightly to enable the detection of hand motion. Funduscopy revealed the absorption of subretinal f luid in the left eye (Fig. 1G and 1H ). Six months after vitrectomy, the silicone oil was removed. One year later, the patient's visual acuity in the left eye had improved to 20 / 500 (Fig. 1I and 1J) .
VHL disease is a dominantly inherited multi-systemic cancer syndrome associated with a mutation in the VHL gene. VHL protein dysfunction leads to upregulation of hypoxia inducible factors, which in turn leads to increased levels of angiogenic cytokines. Angiomatous proliferation is a target for RCHs and is aided by anti-angiogenic treatments. Furthermore, the treatment of RCH is variable and depends on the size, location, and secondary effects. Laser photocoagulation or cryotherapy is the standard treatment for small and medium-sized RCH. PDT for the treatment of peripheral RCH has shown effective results in terms of decreasing regional exudation from large lesions [1, 5] . Furthermore, the complication of massive exudative retinal detachment after PDT is extremely rare; only two cases have been reported worldwide, one of which was managed by emergency vitrectomy [3, 4] . The surgical outcomes of our case and the previous case [3] indicated successful removal of the subretinal fluid and restoration of vision. Unlike previous cases, we also administered an intravitreal injection of bevacizumab; however, this did not prevent massive exudation following PDT.
In summary, our case indicates that treatments for large RCHs in patients with VHL disease must be carefully selected. Although PDT is considered one of the useful treatment options for RCH, PDT combined with an intravitreal injection of bevacizumab can lead to perm anent and severe deterioration of vision because of massive exudative retinal detachment. Therefore, frequent fundus examinations should be performed after PDT. 
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